National Coverage Analysis (NCA)

Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease

CAG-00431R

Expand All | Collapse All

Contacts

Lead Analysts
David Dolan
David.Dolan@cms.hhs.gov
410-786-3365
Lead Medical Officers
Joseph Hutter, M.D.

History of Considerations

History Title ID
Original Consideration Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease CAG-00431N View
First reconsideration Beta Amyloid Positron Emission Tomography in Dementia and Neurodegenerative Disease CAG-00431R You are here